SOLV
Solventum Corp.NYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$11.11B
P/E Ratio
7.21
EPS
$8.88
Beta
—
52W High
$88.20
52W Low
$60.70
50-Day MA
$75.06
200-Day MA
$75.07
Dividend Yield
—
Profit Margin
18.70%
Forward P/E
10.34
PEG Ratio
1.22
About Solventum Corp.
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. The company is headquartered in Saint Paul, Minnesota.
Fundamentals
| Revenue (TTM) | $8.32B |
| Gross Profit (TTM) | $4.46B |
| EBITDA | $1.17B |
| Operating Margin | 7.01% |
| Return on Equity | 38.90% |
| Return on Assets | 2.94% |
| Revenue/Share (TTM) | $47.82 |
| Book Value | $29.10 |
| Price-to-Book | 2.26 |
| Price-to-Sales (TTM) | 1.33 |
| EV/Revenue | 1.87 |
| EV/EBITDA | 6.11 |
| Quarterly Earnings Growth (YoY) | 100.80% |
| Quarterly Revenue Growth (YoY) | -3.70% |
| Shares Outstanding | $173.49M |
| Float | $147.37M |
| % Insiders | 14.96% |
| % Institutions | 73.67% |
Historical Volatility
HV 10-Day
26.21%
HV 20-Day
28.71%
HV 30-Day
33.95%
HV 60-Day
30.90%
HV Rank
70.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($86.58 target)
2
Strong Buy5
Buy6
Hold1
SellData last updated: 3/25/2026